Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001047489 | SCV001211451 | uncertain significance | Cohen syndrome | 2021-08-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003346277 | SCV004051110 | uncertain significance | Inborn genetic diseases | 2023-07-12 | criteria provided, single submitter | clinical testing | The c.9533C>A (p.S3178Y) alteration is located in exon 52 (coding exon 51) of the VPS13B gene. This alteration results from a C to A substitution at nucleotide position 9533, causing the serine (S) at amino acid position 3178 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001047489 | SCV002082715 | uncertain significance | Cohen syndrome | 2020-07-24 | no assertion criteria provided | clinical testing |